AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206 | +33.8% | 20,047 | +19.6% | 0.02% | +25.0% |
| Q1 2023 | $154 | +40.0% | 16,759 | +9.5% | 0.02% | +6.7% |
| Q4 2022 | $110 | -99.8% | 15,310 | +45.2% | 0.02% | +200.0% |
| Q3 2022 | $53,000 | -74.1% | 10,541 | -58.5% | 0.01% | -76.2% |
| Q4 2021 | $205,000 | +111.3% | 25,427 | +75.8% | 0.02% | +110.0% |
| Q4 2020 | $97,000 | -63.7% | 14,461 | -56.2% | 0.01% | -67.7% |
| Q2 2020 | $267,000 | +151.9% | 33,048 | +155.0% | 0.03% | +416.7% |
| Q4 2017 | $106,000 | -23.7% | 12,959 | -1.9% | 0.01% | -14.3% |
| Q3 2017 | $139,000 | – | 13,208 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |